This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biotecon Diagnostics Gmbh. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Cordt Grönewald: Innovator in Nucleic Acid Detection
Introduction
Cordt Grönewald is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the detection of nucleic acids. His work has implications for various applications, including diagnostics and research.
Latest Patents
Grönewald holds a patent for "Nucleic acids and methods for the detection of (spp.)". This patent provides detection means and methods that are specific for the genus, utilizing a target molecule that is abundantly present in cells. His innovative approach enhances the sensitivity and accuracy of nucleic acid detection.
Career Highlights
Grönewald is associated with Biotecon Diagnostics GmbH, a company that specializes in developing diagnostic solutions. His role at the company has allowed him to apply his expertise in nucleic acid detection to real-world challenges. His contributions have been instrumental in advancing the company's technological capabilities.
Collaborations
Grönewald has worked alongside talented colleagues, including Kornelia Berghof-Jäger and Berghof Kornelia. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Cordt Grönewald's work in nucleic acid detection exemplifies the impact of innovative thinking in biotechnology. His patent and contributions to Biotecon Diagnostics GmbH highlight the importance of advancements in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile